Aeromimic ADS-1™
- Advanced aerosol delivery for inhaled drugs.
- Enables precise aerosol delivery to Lung-on-Chip tissues.
- Supports Air/Liquid interface and aerosol exposure testing.
- Simulates respiratory functions to test a wide range of inhalable therapies, including liposomes, nanoparticles, and airborne pathogens
- Delivers reproducible data on drug deposition, absorption, and clearance.
- Accelerates respiratory drug development.
Aeromimic ADS-1™
The Aeromimic ADS-1™ system delivers aerosols precisely to Lung-on-Chip tissues, enabling advanced inhaled drug delivery.
Air/Liquid Interface
Simulating respiratory conditions with dynamic airflow
Low Nebulization volume
Testing with small quantities of drugs, reducing costs
Single-use components
Ensuring a uncontaminated testing environment
Use Cases
Airflow dynamics in optimizing inhalable nanodrug delivery systems, improving nanocarrier design, and tailoring drug dosages and release strategies.